Product Composition & Structure

Search a product, then expand its tree to see how it is built — components, single parts, materials and packaging, each with its share. You always see where you are inside the product, and a click takes you to the companies (actors) that make it.

Pharmaceutical Products incl. Contraceptives and Vaccines › Antineoplastic agents › Tyrosine kinase inhibitors › Nintedanib

Nintedanib

Product ID: 282176
1 materials 1 total parts
View companies that make this product
Filter:
Formulation 1 option — component shares are % of the finished formulation
Nintedanib Soft Capsule 100 mg primary base: Nintedanib esylate Pharmaceutical soft gelatin capsule formulation
ComponentRoleShareSourceable matches
Medium-chain triglycerides Vehicle
50% (40–60)
Clinical chemistry substrates 51% Caprylic acid or Octanoic acid 47% Combination fatty acid nutritional supplement 47% Used In
Gelatin Capsule shell
25% (20–30)
Gelatin or jelly crystals 69% Optical filters 64% Agar-agar 56% Used In
Nintedanib esylate Active pharmaceutical ingredient
15% (10–20)
Nintedanib 85% Vandetanib 59% Pirfenidone 59% Used In
Glycerol Plasticizer
7٫5% (5–10)
Glycerol 93% Glycerine 77% Glycerin/propylene glycol 61% Used In
Titanium dioxide Opacifier
2% (1–3)
Titanium dioxide 90% Titanium oxide 83% Titanium dioxide/zinc oxide 76% Used In
Iron oxide red Colorant
0٫3% (0٫1–0٫5)
Welding and soldering and brazing supplies 61% Clinical chemistry substrates 60% Iron Fe 60% Used In
Lecithin Emulsifier
0٫2% (0٫1–0٫5)
Clinical chemistry substrates 91% Phosphatidylcholine 65% Phospholipids 60% Used In

Interactive Visual Tree Workbench

Explore visual hierarchical nodes, scale batch production quantities, and discover component suppliers.

kg
Component
Material BASE
Percentage (%): 0%
Required Weight: 0 kg
Find Suppliers for this Part